Yield of dual endoscopy for positive fecal occult blood test

Ali, Mirza; Yaqub, Muhammad S.; Haider, Zishan; Anees, Iram; Bhargava, Seema; Gian, John

doi:10.1111/j.1572-0241.2003.07164.x

Cited by 32 publications

(29 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Th ere have been studies evaluating the yield of bidirectional endoscopy ( 22,23 ). Upper gastrointestinal endoscopy may yield important fi ndings in asymptomatic patients with positive fecal occult blood test and negative colonoscopy, especially in patients who present with anemia ( 24,25 ).…”

Section: Discussionmentioning

confidence: 99%

Annual Fecal Occult Blood Testing can be Safely Suspended for up to 5 Years After a Negative Colonoscopy in Asymptomatic Average-Risk Patients

Liu

Finkelstein

François

2015

American Journal of Gastroenterology

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Annual Fecal Occult Blood Testing can be Safely Suspended for up to 5 Years After a Negative Colonoscopy in Asymptomatic Average-Risk Patients

Liu

Finkelstein

François

2015

American Journal of Gastroenterology

View full text Add to dashboard Cite

show abstract

“…1 BDE is especially beneficial for evaluation of various clinical situations, such as active GI bleeding, iron-deficiency anemia, positive fecal occult blood tests, abdominal pain, and cancer screening. 2,[4][5][6] However, the optimal sequence of the two procedures (EGD-colonoscopy versus colonoscopy-EGD) conducted during same-day bidirectional endoscopy has not yet been established. In 2010, Cho et al investigated this question in procedures carried out without sedation, and showed that EGD-colonoscopy is superior to colonoscopy-EGD and that the colonoscopy-EGD sequence is more stressful to patients.…”

Section: Introductionmentioning

confidence: 99%

Comparison of procedural sequences in same‐day painless bidirectional endoscopy: Single‐center, prospective, randomized study

Cao

Yang

et al. 2017

Digestive Endoscopy

View full text Add to dashboard Cite

Background and Aim: To compare the efficacy and safety of esophagogastroduodenoscopy (EGD)-colonoscopy and colonoscopy-EGD sequences for patients subjected to same-day bidirectional endoscopy under remifentanil and propofol sedation.Methods: A total of 209 eligible outpatients scheduled for diagnostic same-day bidirectional endoscopy between 16 February 2016 and 30 April 2016 were randomly assigned to the EGDcolonoscopy (n = 106) and colonoscopy-EGD (n = 103) sequence groups. Primary endpoint was total dose of propofol required for the procedure. Secondary endpoints included duration of endoscopy, patient satisfaction, adverse effects, endoscopy findings, and cardiopulmonary responses of the patients.Results: Patients in the two groups were similar in terms of demographic and clinical data (P > 0.05). EGD-colonoscopy sequence group had lesser requirement of propofol for sedation (P < 0.05), faster recovery (P < 0.001), and lesser influence on mean arterial pressure (MAP) during the endoscopy (P < 0.05). Duration of EGD and colonoscopy, patient satisfaction, adverse effects, and pathological findings did not differ between the two groups. Conclusions:The EGD-colonoscopy sequence may be considered the preferred sequence for same-day bidirectional endoscopy as a result of less cardiovascular stress, lessened need for sedation with propofol, and faster recovery.

show abstract

“…6,7 Studies reviewing causes for FOBt positivity outside of a formal screening programme have reported a wide variation in NNF of 5-45%. 8,9 This variation may be due to methods of reporting. Diverticular disease and haemorrhoids are variably reported, with some studies suggesting that these findings would not cause FOBt positivity.…”

Section: Introductionmentioning

confidence: 99%

“…Diverticular disease and haemorrhoids are variably reported, with some studies suggesting that these findings would not cause FOBt positivity. 8,9 The aim of this study was to describe NNF generated by the BCSP, in terms of frequency and nature of findings made.…”

Section: Introductionmentioning

confidence: 99%

Non-neoplastic findings at colonoscopy after positive faecal occult blood testing: Data from the English Bowel Cancer Screening Programme

Bevan¹,

Lee²,

Nickerson

et al. 2014

J Med Screen

View full text Add to dashboard Cite

Background: The aim of the English Bowel Cancer Screening Programme (BCSP) is to diagnose early colorectal cancer and advanced adenomas. However, other findings are also reported at screening colonoscopy. Small studies demonstrate findings other than cancer or adenomas (non-neoplastic findings (NNF)) in 11-25%. Objectives and setting: Describe the frequency and nature of NNF within the BSCP. Methods: Data were obtained from the BCSP national database for all individuals undergoing colonoscopic investigation after positive faecal occult blood testing between August 2006 and November 2011. Data included demographics, smoking status, neoplastic findings and NNF. Results: 121728 colonoscopies were analysed. 51 NNF were found in 26251 cases (21.6%). Diverticular disease (18875 cases) and haemorrhoids (7011) were the most frequently reported. Inflammatory bowel disease (IBD) was reported in 2152 cases. Individuals with a neoplastic diagnosis were less likely to have an NNF than those without (19.8% v 24.4%, p < 0.001). After adjustment for confounding using multivariable analysis, older age was still associated with a small but statistically significant risk of NNF. Conclusions: The BCSP generates a significant volume of NNF. A small proportion of individuals were found to have inflammatory bowel disease (IBD) -an important diagnosis with implications for long-term management. BCSP participants should be aware that findings other than neoplasia may be detected and the relevance of these findings to that individual is not known. Reporting of NNF varies between colonoscopists, and potential underreporting is a limitation of this study. Further study is required to establish the impact of NNF on primary and secondary care.

show abstract

Yield of dual endoscopy for positive fecal occult blood test

Cited by 32 publications

References 10 publications

Annual Fecal Occult Blood Testing can be Safely Suspended for up to 5 Years After a Negative Colonoscopy in Asymptomatic Average-Risk Patients

Annual Fecal Occult Blood Testing can be Safely Suspended for up to 5 Years After a Negative Colonoscopy in Asymptomatic Average-Risk Patients

Comparison of procedural sequences in same‐day painless bidirectional endoscopy: Single‐center, prospective, randomized study

Non-neoplastic findings at colonoscopy after positive faecal occult blood testing: Data from the English Bowel Cancer Screening Programme

Contact Info

Product

Resources

About